Bookbuilding IPO | ₹30 Cr | Listed at NSE SME | Wed, May 14, 2025 - Fri, May 16, 2025
Accretion Pharmaceuticals IPO IPO subscription status. Full data available on IPOMatrix.com.
| Category | QIB | NII | Retail | Total | ||
|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor Investor | Total QIB | ||||
| Allocation (No. of shares) | 27,98,400 | |||||
| Allotment price (₹) | 101 | |||||
| No. of applications | 11,706 | |||||
| No. of shares applied | 1,80,99,600 | |||||
|
🔒 Preview Limited Full data is available exclusively on IPOMatrix.com — your premium IPO research platform. 🗝️ Login to View All Records → |
||||||
| Amount collected (₹ Cr.) | 182.81 Cr | |||||
| No. of times subscribed | 6.47 | |||||
| No. of shares allotted | 27,98,400 | |||||
| Amount allotted (₹ Cr.) | 28.26 Cr | |||||
| No. of allottees | 11,350 | |||||
Accretion Pharmaceuticals IPO is a public issue of 0.28 Cr equity shares. The issue offers 0.12 Cr shares to retail investors, 0.04 Cr shares to qualified institutional buyers, and 0.12 Cr shares to non-institutional investors.
| Category | Shares Offered | Amt (₹ Cr.) | Size (%) |
|---|---|---|---|
| Market Maker | 1,47,600 | 1.49 | 5.01% |
| QIB | 3,52,800 | 3.56 | 11.98% |
| Anchor | 2,11,200 | 2.13 | 7.17% |
| QIB (Ex Anchor) | 1,41,600 | 1.43 | 4.81% |
| NII* | 12,22,800 | 12.35 | 41.51% |
| Retail | 12,22,800 | 12.35 | 41.51% |
| Total | 29,46,000 | 29.75 | 100% |
A total of 2,11,200 shares at a price of Rs 101 per share will be allotted to the anchor investors.
| Bid Date | May 13, 2025 |
| Price | ₹101.00 |
| % of QIBs | 59.86% |
| Shares Locked (30 Days) | 1,05,600 |
| Shares Locked (90 Days) | 1,05,600 |
| # | Anchor | Group Entity | Shares Allotted | Amt (₹ cr.) | % Allocated | % Allotment of Issue |
|---|---|---|---|---|---|---|
| 1 | PINE OAK GLOBAL FUND | PINE OAK | 1,05,600 | 1.07 | 50.00 | 3.58 |
| 2 | VIKASA CAPITAL INC. | VIKASA | 1,05,600 | 1.07 | 50.00 | 3.58 |
📊 Historic report - IPOs Anchor Investors Investment & Performance
The Accretion Pharmaceuticals IPO is subscribed 6.47x.
Category-wise data available on IPOMatrix.com
Login to view QIB, NII, Retail and all category details
| Category | Subscription (times) |
|---|---|
| Total | 6.47x |
Accretion Pharmaceuticals IPO total subscription is 6.47x.
Category-wise data available on IPOMatrix.com
Login to view QIB, NII, Retail and all category details
An investor can apply in Accretion Pharmaceuticals IPO online via bank (using ASBA) or the broker (using UPI). The Accretion Pharmaceuticals IPO shares are offered online only.
The Accretion Pharmaceuticals IPO is subscribed 6.47x times.
The Accretion Pharmaceuticals IPO allotment status is expected on or around Monday, May 19, 2025. Visit Accretion Pharmaceuticals IPO allotment status to check.
The Accretion Pharmaceuticals IPO listing date is May 21, 2025. The equity share of Accretion Pharmaceuticals IPO will list on NSE SME.
Visit Accretion Pharmaceuticals IPO subscription status page for real-time bidding information about Accretion Pharmaceuticals IPO.
| IPO opens On | Wednesday, May 14, 2025 |
| IPO Closes On | Friday, May 16, 2025 |
| Finalisation of Basis of Allotment | Monday, May 19, 2025 |
| Initiation of Refunds | Tuesday, May 20, 2025 |
| Credit of Shares to Demat Account | Tuesday, May 20, 2025 |
| IPO Listing Date | Wednesday, May 21, 2025 |
| IPO Details |
| IPO Recommendations |
| IPO Live Subscription |
| IPO FAQs |
